Commodore Capital LP Diversified Active

Location: New York, NY

CIK: 0001831942 · Show all filings

Period: Q4 2023 (← Previous) (Next →)

Filing Date: Feb 14, 2024

Total Value: $1.144B (100.0% shares, 0.0% debt)

Holdings (32)

— MERUS N V 11.4%

Value $131M Shares 4,747,373 Est. Cost $25.16 Unrealized —

XENE XENON PHARMACEUTICALS INC 8.7%

Value $99.85M Shares 2,167,793 Est. Cost $27.44 Unrealized +28.8%

NUVL NUVALENT INC 8.6%

Value $97.95M Shares 1,331,037 Est. Cost $41.27 Unrealized +50.0%

VERA VERA THERAPEUTICS INC 7.3%

Value $83.82M Shares 5,450,000 Est. Cost $8.35 Unrealized +52.1%

RYTM RHYTHM PHARMACEUTICALS INC 6.2%

Value $71.25M Shares 1,550,000 Est. Cost $22.39 Unrealized +40.9%

PCVX VAXCYTE INC 6.0%

Value $69.08M Shares 1,100,000 Est. Cost $46.14 Unrealized +12.6%

CABA CABALETTA BIO INC 3.8%

Value $43.13M Shares 1,900,000 Est. Cost $7.66 Unrealized +119.6%

IMVT IMMUNOVANT INC 3.7%

Value $42.13M Shares 1,000,000 Est. Cost $14.46 Unrealized +154.5%

VRDN VIRIDIAN THERAPEUTICS INC 3.7%

Value $41.91M Shares 1,924,074 Est. Cost $17.59 Unrealized -10.2%

ARVN ARVINAS INC 3.6%

Value $41.16M Shares 1,000,000 Est. Cost $23.38 Unrealized 0.0%

SYRE SPYRE THERAPEUTICS INC 3.5%

Value $40.55M Shares 1,884,084 Est. Cost $13.74 Unrealized +0.3%

ELVN ENLIVEN THERAPEUTICS INC 3.5%

Value $40.16M Shares 2,901,816 Est. Cost $19.64 Unrealized -37.7%

COGT COGENT BIOSCIENCES INC 2.9%

Value $32.73M Shares 5,566,026 Est. Cost $8.92 Unrealized -14.1%

— ALPINE IMMUNE SCIENCES INC 2.7%

Value $30.69M Shares 1,610,000 Est. Cost $9.30 Unrealized —

SLNO SOLENO THERAPEUTICS INC 2.5%

Value $28.18M Shares 700,000 Est. Cost $6.05 Unrealized +370.0%

CLDX CELLDEX THERAPEUTICS INC NEW 2.4%

Value $27.84M Shares 701,967 Est. Cost $31.10 Unrealized -5.4%

CELC CELCUITY INC 2.2%

Value $25.57M Shares 1,754,704 Est. Cost $18.27 Unrealized -33.9%

— RAYZEBIO INC 2.1%

Value $23.85M Shares 383,638 Est. Cost $32.07 Unrealized —

PHVS PHARVARIS N V 2.0%

Value $22.44M Shares 800,000 Est. Cost $20.23 Unrealized 0.0%

CCCC C4 THERAPEUTICS INC 1.9%

Value $21.47M Shares 3,800,000 Est. Cost $2.28 Unrealized 0.0%

ABVX ABIVAX SA 1.8%

Value $20.28M Shares 1,895,003 Est. Cost $10.70 Unrealized —

NKTX NKARTA INC 1.6%

Value $18.02M Shares 2,730,000 Est. Cost $2.59 Unrealized 0.0%

KURA KURA ONCOLOGY INC 1.6%

Value $17.95M Shares 1,248,062 Est. Cost $13.92 Unrealized -29.4%

— HARPOON THERAPEUTICS INC 1.5%

Value $17.05M Shares 1,500,000 Est. Cost $11.37 Unrealized —

— AKERO THERAPEUTICS INC 1.2%

Value $13.19M Shares 565,000 Est. Cost $41.36 Unrealized —

DYN DYNE THERAPEUTICS INC 1.0%

Value $11.97M Shares 900,000 Est. Cost $9.77 Unrealized 0.0%

VTGN VISTAGEN THERAPEUTICS INC 0.7%

Value $8.095M Shares 1,575,000 Est. Cost $4.44 Unrealized -14.8%

— THIRD HARMONIC BIO INC 0.7%

Value $7.753M Shares 706,706 Est. Cost $13.74 Unrealized —

— ADVERUM BIOTECHNOLOGIES INC 0.7%

Value $7.528M Shares 10,000,000 Est. Cost $1.15 Unrealized —

APGE APOGEE THERAPEUTICS INC 0.6%

Value $6.985M Shares 250,000 Est. Cost $22.03 Unrealized -9.0%

SABS SAB BIOTHERAPEUTICS INC 0.1%

Value $1.259M Shares 1,831,746 Est. Cost $8.38 Unrealized 0.0%

— DBV TECHNOLOGIES S A 0.0%

Value $88,312 Shares 92,687 Est. Cost $1.53 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
—	MERUS N V	4,747,373	$131M	11.4%	$25.16	—	COM	N5749R100
XENE	XENON PHARMACEUTICALS INC	2,167,793	$99.85M	8.7%	$27.44	+28.8%	COM	98420N105
NUVL	NUVALENT INC	1,331,037	$97.95M	8.6%	$41.27	+50.0%	COM	670703107
VERA	VERA THERAPEUTICS INC	5,450,000	$83.82M	7.3%	$8.35	+52.1%	CL A	92337R101
RYTM	RHYTHM PHARMACEUTICALS INC	1,550,000	$71.25M	6.2%	$22.39	+40.9%	COM	76243J105
PCVX	VAXCYTE INC	1,100,000	$69.08M	6.0%	$46.14	+12.6%	COM	92243G108
CABA	CABALETTA BIO INC	1,900,000	$43.13M	3.8%	$7.66	+119.6%	COM	12674W109
IMVT	IMMUNOVANT INC	1,000,000	$42.13M	3.7%	$14.46	+154.5%	COM	45258J102
VRDN	VIRIDIAN THERAPEUTICS INC	1,924,074	$41.91M	3.7%	$17.59	-10.2%	COM	92790C104
ARVN	ARVINAS INC	1,000,000	$41.16M	3.6%	$23.38	0.0%	COM	04335A105
SYRE	SPYRE THERAPEUTICS INC	1,884,084	$40.55M	3.5%	$13.74	+0.3%	COM NEW	00773J202
ELVN	ENLIVEN THERAPEUTICS INC	2,901,816	$40.16M	3.5%	$19.64	-37.7%	COM	29337E102
COGT	COGENT BIOSCIENCES INC	5,566,026	$32.73M	2.9%	$8.92	-14.1%	COM	19240Q201
—	ALPINE IMMUNE SCIENCES INC	1,610,000	$30.69M	2.7%	$9.30	—	COM	02083G100
SLNO	SOLENO THERAPEUTICS INC	700,000	$28.18M	2.5%	$6.05	+370.0%	COM	834203309
CLDX	CELLDEX THERAPEUTICS INC NEW	701,967	$27.84M	2.4%	$31.10	-5.4%	COM NEW	15117B202
CELC	CELCUITY INC	1,754,704	$25.57M	2.2%	$18.27	-33.9%	COM	15102K100
—	RAYZEBIO INC	383,638	$23.85M	2.1%	$32.07	—	COM	75525N107
PHVS	PHARVARIS N V	800,000	$22.44M	2.0%	$20.23	0.0%	COM	N69605108
CCCC	C4 THERAPEUTICS INC	3,800,000	$21.47M	1.9%	$2.28	0.0%	COM STK	12529R107
ABVX	ABIVAX SA	1,895,003	$20.28M	1.8%	$10.70	—	SPONSORED ADS	00370M103
NKTX	NKARTA INC	2,730,000	$18.02M	1.6%	$2.59	0.0%	COM	65487U108
KURA	KURA ONCOLOGY INC	1,248,062	$17.95M	1.6%	$13.92	-29.4%	COM	50127T109
—	HARPOON THERAPEUTICS INC	1,500,000	$17.05M	1.5%	$11.37	—	COM NEW	41358P205
—	AKERO THERAPEUTICS INC	565,000	$13.19M	1.2%	$41.36	—	COM	00973Y108
DYN	DYNE THERAPEUTICS INC	900,000	$11.97M	1.0%	$9.77	0.0%	COM	26818M108
VTGN	VISTAGEN THERAPEUTICS INC	1,575,000	$8.095M	0.7%	$4.44	-14.8%	COM	92840H400
—	THIRD HARMONIC BIO INC	706,706	$7.753M	0.7%	$13.74	—	COM	88427A107
—	ADVERUM BIOTECHNOLOGIES INC	10,000,000	$7.528M	0.7%	$1.15	—	COM	00773U108
APGE	APOGEE THERAPEUTICS INC	250,000	$6.985M	0.6%	$22.03	-9.0%	COM	03770N101
SABS	SAB BIOTHERAPEUTICS INC	1,831,746	$1.259M	0.1%	$8.38	0.0%	COM	78397T202
—	DBV TECHNOLOGIES S A	92,687	$88,312	0.0%	$1.53	—	SPONSORED ADR	23306J101